Collegium Pharmaceutical, Inc. (COLL) Free cash flow 2016–2025
Collegium Pharmaceutical, Inc. (COLL) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$327.6MFY2025 · since FY2016: -$75.5M → $327.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $327.6M | +61.1% |
| FY2024 | $203.3M | -25.9% |
| FY2023 | $274.3M | +123.7% |
| FY2022 | $122.6M | +20.7% |
| FY2021 | $101.6M | +15.0% |
| FY2020 | $88.4M | +314.1% |
| FY2019 | $21.3M | -87.0% |
| FY2018 | $163.9M | +341.0% |
| FY2017 | -$68.0M | +10.0% |
| FY2016 | -$75.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More COLL financial trends
COLL RevenueCOLL Net incomeCOLL Net marginCOLL Gross profitCOLL Gross marginCOLL Operating incomeCOLL Operating marginCOLL Operating cash flowCOLL Capital expendituresCOLL Return on equityCOLL Stock buybacksCOLL Dividends paidCOLL Total assetsCOLL Total liabilitiesCOLL Shareholders’ equityCOLL overview →